vs
Aligos Therapeutics, Inc.（ALGS）与ASTROTECH Corp（ASTC）财务数据对比。点击上方公司名可切换其他公司
Aligos Therapeutics, Inc.的季度营收约是ASTROTECH Corp的1.1倍（$169.0K vs $148.0K），ASTROTECH Corp同比增速更快（-43.3% vs -72.1%），过去两年ASTROTECH Corp的营收复合增速更高（-40.2% vs -50.7%）
Aligos Therapeutics是一家临床阶段生物制药企业，专注于开发针对流行性肝病与病毒感染的新型靶向疗法，核心管线覆盖慢性乙型肝炎、非酒精性脂肪性肝炎等适应症，通过自主研发推进药物落地，满足全球未被满足的医疗需求。
航天科技公司（原名Spacehab Inc.）是一家总部位于美国得克萨斯州奥斯汀的科技孵化企业。该公司整合内部、研究机构、政府实验室及高校的技术资源，投资、孵化并退出初创企业，旗下子公司还为美国航空航天局、美国国防部、各国航天机构及全球商业客户提供商业化产品与服务。
ALGS vs ASTC — 直观对比
营收规模更大
ALGS
是对方的1.1倍
$148.0K
营收增速更快
ASTC
高出28.8%
-72.1%
两年增速更快
ASTC
近两年复合增速
-50.7%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $169.0K | $148.0K |
| 净利润 | — | $-3.9M |
| 毛利率 | — | 5.4% |
| 营业利润率 | — | -2635.8% |
| 净利率 | — | -2653.4% |
| 营收同比 | -72.1% | -43.3% |
| 净利润同比 | 75.8% | 2.0% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALGSASTC
| Q4 25 | $169.0K | $148.0K | ||
| Q3 25 | $741.0K | $297.0K | ||
| Q2 25 | $965.0K | $220.0K | ||
| Q1 25 | $311.0K | $534.0K | ||
| Q4 24 | $606.0K | $261.0K | ||
| Q3 24 | $1.3M | — | ||
| Q2 24 | $1.1M | — | ||
| Q1 24 | $694.0K | — |
净利润ALGSASTC
| Q4 25 | — | $-3.9M | ||
| Q3 25 | $-31.5M | $-3.5M | ||
| Q2 25 | $-15.9M | $-2.9M | ||
| Q1 25 | $43.1M | $-3.6M | ||
| Q4 24 | $-82.2M | $-4.0M | ||
| Q3 24 | $-19.3M | — | ||
| Q2 24 | $5.1M | — | ||
| Q1 24 | $-34.9M | — |
毛利率ALGSASTC
| Q4 25 | — | 5.4% | ||
| Q3 25 | — | 63.3% | ||
| Q2 25 | — | 33.6% | ||
| Q1 25 | — | 44.4% | ||
| Q4 24 | — | 59.4% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ALGSASTC
| Q4 25 | — | -2635.8% | ||
| Q3 25 | -3827.4% | -1190.6% | ||
| Q2 25 | -1924.0% | -1326.4% | ||
| Q1 25 | -6187.5% | -724.2% | ||
| Q4 24 | -3393.2% | -1655.6% | ||
| Q3 24 | -1610.5% | — | ||
| Q2 24 | -2489.5% | — | ||
| Q1 24 | -3176.7% | — |
净利率ALGSASTC
| Q4 25 | — | -2653.4% | ||
| Q3 25 | -4256.0% | -1166.7% | ||
| Q2 25 | -1643.8% | -1331.8% | ||
| Q1 25 | 13854.7% | -680.3% | ||
| Q4 24 | -13556.1% | -1536.0% | ||
| Q3 24 | -1540.7% | — | ||
| Q2 24 | 477.0% | — | ||
| Q1 24 | -5023.5% | — |
每股收益（稀释后）ALGSASTC
| Q4 25 | — | — | ||
| Q3 25 | $-3.04 | — | ||
| Q2 25 | $-1.53 | — | ||
| Q1 25 | $-2.11 | — | ||
| Q4 24 | $-13.10 | — | ||
| Q3 24 | $-3.07 | — | ||
| Q2 24 | $0.81 | — | ||
| Q1 24 | $-5.58 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $77.8M | $7.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $53.5M | $15.5M |
| 总资产 | $88.5M | $19.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALGSASTC
| Q4 25 | $77.8M | $7.0M | ||
| Q3 25 | $99.1M | $11.3M | ||
| Q2 25 | $122.9M | $15.1M | ||
| Q1 25 | $137.9M | $18.1M | ||
| Q4 24 | $56.9M | $21.5M | ||
| Q3 24 | $74.9M | — | ||
| Q2 24 | $94.5M | — | ||
| Q1 24 | $112.7M | — |
股东权益ALGSASTC
| Q4 25 | $53.5M | $15.5M | ||
| Q3 25 | $71.8M | $19.1M | ||
| Q2 25 | $101.9M | $22.1M | ||
| Q1 25 | $116.4M | $24.8M | ||
| Q4 24 | $-29.0M | $28.1M | ||
| Q3 24 | $50.1M | — | ||
| Q2 24 | $67.2M | — | ||
| Q1 24 | $59.8M | — |
总资产ALGSASTC
| Q4 25 | $88.5M | $19.7M | ||
| Q3 25 | $109.8M | $23.2M | ||
| Q2 25 | $134.7M | $27.0M | ||
| Q1 25 | $150.7M | $27.5M | ||
| Q4 24 | $70.1M | $31.0M | ||
| Q3 24 | $88.4M | — | ||
| Q2 24 | $108.8M | — | ||
| Q1 24 | $127.9M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-82.5M | $-3.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-4.0M |
| 自由现金流率自由现金流/营收 | — | -2671.6% |
| 资本支出强度资本支出/营收 | — | 277.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-14.9M |
8季度趋势，按日历期对齐
经营现金流ALGSASTC
| Q4 25 | $-82.5M | $-3.5M | ||
| Q3 25 | $-24.3M | $-3.9M | ||
| Q2 25 | $-15.5M | $-2.4M | ||
| Q1 25 | $-20.9M | $-3.9M | ||
| Q4 24 | $-18.4M | $-3.0M | ||
| Q3 24 | $-20.1M | — | ||
| Q2 24 | $-19.5M | — | ||
| Q1 24 | $-22.7M | — |
自由现金流ALGSASTC
| Q4 25 | — | $-4.0M | ||
| Q3 25 | — | $-4.4M | ||
| Q2 25 | — | $-2.7M | ||
| Q1 25 | — | $-3.9M | ||
| Q4 24 | — | $-3.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ALGSASTC
| Q4 25 | — | -2671.6% | ||
| Q3 25 | — | -1476.1% | ||
| Q2 25 | — | -1231.4% | ||
| Q1 25 | — | -728.1% | ||
| Q4 24 | — | -1288.5% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ALGSASTC
| Q4 25 | — | 277.7% | ||
| Q3 25 | — | 150.8% | ||
| Q2 25 | — | 158.2% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 122.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ALGSASTC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.49× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -3.85× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
